Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
September 13 - October 12, 2004
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Remarks:
According to OECD 402 Guideline, with GLP.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2004
Report date:
2004

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Deviations:
no
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
A mixture of: propan-2-one-O,O'(methoxyvinylsilandiyl)dioxime; propan-2-one-O-(dimethoxyvinylsilyl)oxime; propan-2-one-O,O',O''-(vinylsilantriyl)trioxime
EC Number:
458-680-3
EC Name:
A mixture of: propan-2-one-O,O'(methoxyvinylsilandiyl)dioxime; propan-2-one-O-(dimethoxyvinylsilyl)oxime; propan-2-one-O,O',O''-(vinylsilantriyl)trioxime
Cas Number:
797751-44-1
Molecular formula:
not applicable, multiconstituent substance
IUPAC Name:
3-ethenyl-3-methoxy-6-methyl-2,4-dioxa-5-aza-3-silahept-5-ene; 5-ethenyl-2,8-dimethyl-5-{[(propan-2-ylidene)amino]oxy}-4,6-dioxa-3,7-diaza-5-silanona-2,7-diene; 5-ethenyl-5-methoxy-2,8-dimethyl-4,6-dioxa-3,7-diaza-5-silanona-2,7-diene
Test material form:
liquid

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Wiga
- Age at study initiation: approximately 8 weeks (males) and 12 weeks (females)
- Weight at study initiation: 245-254g (males) and 229-240 g (females)
- Housing: single caging in Makrolon cages type III
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): average 22 ºC
- Humidity (%): average 56%
- Air changes (per hr): 12 per hour
- Photoperiod (hrs dark / hrs light): artificial light from 6 a.m. to 6 p.m.

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
TEST SITE
- Area of exposure: an area of 6.5 cm x 8 cm (52 cm2) on the dorsal thoracal region
- % coverage: at least 10% of the estimated body surface

REMOVAL OF TEST SUBSTANCE
- Washing (if done): if necessary, residual test substance was wiped off using cellulose tissue
- Time after start of exposure: 24 hours

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg per kg body weight
Duration of exposure:
24 hours
Doses:
One dose level of 2000 mg/kg body weight
No. of animals per sex per dose:
5 males and 5 females
Control animals:
not required
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations were performed 0 - 0.5, > 0.5 - 1, > 1 - 2, > 2 - 4 and > 4 - 6 hours after administration of the test substance and then at least once a day for a total of 2 weeks. Body weights were determinate before administration, 7 and 14 days after administration.
- Necropsy of survivors performed: yes

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
Male: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 0
Female: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 0
Clinical signs:
other: No relevant findings in life were noted, except for signs of discomfort in 1 male rat a day after the test substance administration. The clinical signs were chromodacryorrhoea, attributed to the discomfort caused by the dressing and was not considered to
Gross pathology:
Effect on organs: no relevant findings were noted.
Other findings:
No relevant local findings were noted.

Any other information on results incl. tables

Body weights and body weight gain:

 

Individual data, mean and standard deviation SD

Sex

No.

before
administr.

7 days
p.a.

14 days
p.a.

death

0-7 days
p.a.

7-14 days
p.a.

 

11

253

276

320

-

23

44

2000 mg/kg

12

251

298

351

-

47

53

male

13

245

278

322

-

33

44

 

14

246

268

311

-

22

43

 

15

254

284

332

-

30

48

 

mean

250

281

327

-

31.0

46.4

 

SD

4

11

15

-

10.1

4.2

 

16

239

244

263

-

5

19

2000 mg/kg

17

236

241

263

-

5

22

female

18

240

249

266

-

9

17

 

19

234

241

257

-

7

16

 

20

229

232

254

-

3

22

 

mean

236

241

261

-

5.8

19.2

 

SD

4

6

5

-

2.3

2.8

Synopsis of Results

dose
(mg/kg)

sex

No. of animals

prominent findings

exposed

affected

deceased

in life

post mortem

 

 

 

 

 

systemic

local

 

2000

male

5

1

0

signs of discomfort

none

none

2000

female

5

0

0

none

none

none

presence of clinical signs

1 d p.a.

full recovery of the survivors

yes

body weights

all animals gained weight in the weeks after dosing

sex differences

no

findings in life and post-mortem indicate

no toxic effects

 

 

LD50, dermal

> 2000 mg/kg body weight

Applicant's summary and conclusion

Interpretation of results:
other: Not classified (CLP Regulation EC no. 1272/2008)
Conclusions:
No test substance related effects were noted from clinical observations or post-mortem examination at a dose of 2000 mg test substance per kg body weight.
The LD50, dermal of the test substance is > 2000 mg/kg body weight in rats.
Executive summary:

The Acute Dermal Toxicity assay for the test substance was performed (According to OECD 402 Guideline) in Sprague Dawley rats. One female group and one male group, of 5 animals each one, were treated with a single dose of 2000 mg/kg body weight (Limit test). The test material was applied via a patch to an area of approximately 6.5 x 8 cm on the dorsal thoracal region, and covered by a semi-occlusive dressing. The duration of the exposure was 24 hours.

Clinical observation was conducted at 0 - 0.5, > 0.5 - 1, > 1 - 2, > 2 - 4 and > 4 - 6 hours after administration of the test substance and then at least once a day for a total of 2 weeks. Body weight was controlled before the administration, 7 and 14 days after the administration. All animals were subjected to gross necropsy.

No test substance related effects were noted from clinical observations or post-mortem examination at a dose of 2000 mg test substance per kg body weight. The LD50dermal of the test substance was > 2000 mg/kg body weight in rats.